Robuta

https://www.takeda.com/en-ca/newsroom/2026/fruzaqla-ontario-metastatic-colorectal-cancer-treatment/
Fruzaqla capsules now funded in Ontario for metastatic colorectal cancer, offering new hope for patients. Learn more about its benefits and availability.
colorectal cancer treatmentfruzaqlaontario
https://www.takeda.com/newsroom/newsreleases/2024/approval-from-european-commission-for-fruzaqla/
Takeda secures European Commission approval for FRUZAQLA (fruquintinib), a novel targeted therapy for previously treated metastatic colorectal cancer. Learn...
metastatic colorectal cancereuropean commissionfruzaqlareceivesapproval